Suppr超能文献

中药PHY906治疗结肠癌的关键通路和基因

The Significant Pathways and Genes Underlying the Colon Cancer Treatment by the Traditional Chinese Medicine PHY906.

作者信息

Su Ziyuan, Zhou Changyu, Qin Shaoyou, Jia Erna, Wu Zhenting

机构信息

Research Center of TCM, The Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, China.

Digest Department, China-Japan Union Hospital of Jilin University, Changchun, China.

出版信息

Evid Based Complement Alternat Med. 2017;2017:8753815. doi: 10.1155/2017/8753815. Epub 2017 May 15.

Abstract

BACKGROUND

We attempted to explore the molecular mechanism underlying PHY906 intervention of colon cancer.

METHODS

The microarray data of tumors treated by PHY906 and PBS alone were downloaded from the public Gene Expression Omnibus database. The dataset was further analyzed for the differentially expressed genes (DEGs) and their related biological functions were analyzed, followed by function and pathways. Protein-protein interaction (PPI) network was constructed and the significant nodes were screened by network centralities and then the significant modules analysis. Besides, they were clustered and transcriptional factors (TFs) were predicted.

RESULTS

The gene expression patterns changed induced by PHY906 treatment, including 414 upregulated and 337 downregulated DEGs. The biological process of response to steroid hormone stimulus and regulation of interferon-gamma production were significantly enriched by DEGs. Ezh2 (enhancer of zeste 2) was found to be the key node in PPI network. There are 12 significant TFs predicted for module 1 genes and 3 TFs for module 2 genes.

CONCLUSIONS

PHY906 treatment may function in protecting the epithelial barrier against tumor cell invasion by modulating IFN- level and mediating cancer cell death by activating the response to steroid hormone stimulus and activating the response to steroid hormone stimulus. E2f1, Hsfy2, and Nfyb may be therapeutic targets for colon cancer. PHY906 showed treatment efficacy in modulating cell apoptosis by intervening interferon-gamma production and response to steroid hormone stimulus. Ezh2 and its TFs such as E2f1, Hsfy2, and Nfyb may be the potential therapeutic targets for anticancer agents development.

摘要

背景

我们试图探究PHY906干预结肠癌的分子机制。

方法

从公共基因表达综合数据库下载单独用PHY906和PBS处理的肿瘤的微阵列数据。进一步分析该数据集以找出差异表达基因(DEGs),并分析其相关生物学功能,随后进行功能和通路分析。构建蛋白质-蛋白质相互作用(PPI)网络,通过网络中心性筛选重要节点,然后进行重要模块分析。此外,对它们进行聚类并预测转录因子(TFs)。

结果

PHY906处理诱导基因表达模式发生变化,包括414个上调和337个下调的DEGs。DEGs显著富集了对类固醇激素刺激的反应和干扰素-γ产生的调节等生物学过程。发现Ezh2(zeste 2增强子)是PPI网络中的关键节点。模块1基因预测有12个重要TFs,模块2基因有3个TFs。

结论

PHY906治疗可能通过调节IFN水平和激活对类固醇激素刺激的反应来介导癌细胞死亡,从而保护上皮屏障免受肿瘤细胞侵袭。E2f1、Hsfy2和Nfyb可能是结肠癌的治疗靶点。PHY906通过干预干扰素-γ产生和对类固醇激素刺激的反应,在调节细胞凋亡方面显示出治疗效果。Ezh2及其TFs如E2f1、Hsfy2和Nfyb可能是抗癌药物开发的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fe0/5447272/a68cfebfd872/ECAM2017-8753815.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验